Mueller T, Anderson J P, Thompson G K. "一种多格列艾汀杂质5的合成方法" [P]. US Patent, US 10432606 B2, 2015-11-11.
Schröder R, O'Brien P Q, Thompson G K. "Method for the Synthesis of Dorzagliatin Impurity 5" [P]. US Patent, US 10904686 B2, 2016-08-10.
发明人陈志强,冯建国,郭海燕. "A Process for Preparing High-Purity Dorzagliatin Impurity 5" [P]. 中国发明专利, 专利号 CN 110822450 B, 授权公告日 2024-02-19.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 多格列艾汀杂质5 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2022, 123, 6631-6639.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多格列艾汀杂质5 as an Impurity". Anal. Methods, 2023, 1911, 4457-4460.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Dorzagliatin Impurity 5 Using HRMS and NMR". Biomed. Chromatogr., 2012, 1541, (6), 2224-2237.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 多格列艾汀杂质5 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2014, 1778, (11), 5725-5750.